Please login to the form below

Not currently logged in
Email:
Password:

product launches

This page shows the latest product launches news and features for those working in and with pharma, biotech and healthcare.

GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy

GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy

The company will use these funds to strengthen its pipeline, invest in successful product launches, enhance the sustainability of its operations and underpin its ‘progressive’ dividend policy. ... By 2031, GSK is expecting product sales to reach

Latest news

  • W2O rebrands as ‘health innovation company’ Real Chemistry W2O rebrands as ‘health innovation company’ Real Chemistry

    Real Chemistry can do this for clinical trials, new product launches and commercialisation opportunities – all focused on successfully navigating product lifecycles to ultimately improve health outcomes, in partnership with our clients,”

  • Teva’s weak pipeline hit by Tourette’s drug trial failure Teva’s weak pipeline hit by Tourette’s drug trial failure

    Drug wasn't able to improve on placebo. Teva’s effort to reinvigorate its business with new product launches has suffered a setback after a drug for Tourette’s syndrome failed ... Full-year growth was higher at more than 100%. Teva said before the

  • Pharma Brand Planners' Blog (Part 7) Pharma Brand Planners' Blog (Part 7)

    A few statistics feel useful here to support our theme:. Across all major industries, 72% of all product launches fail to meet their revenue targets.

  • Novo bolstered by new diabetes, obesity products Novo bolstered by new diabetes, obesity products

    It is the first oral alternative to injectable GLP-1 agonists, and has also been touted by Novo as a potential blockbuster product. ... While Novo has traditionally relied on its US insulin for much of its revenues, its new product launches have offset

  • Healthcare’s voice revolution Healthcare’s voice revolution

    task with limited added value, especially when the technology lacks the verifiable, robust evidence they are used to seeing accompanying new product launches.

More from news
Approximately 0 fully matching, plus 129 partially matching documents found.

Latest Intelligence

  • Product launches: making the most of your one shot Product launches: making the most of your one shot

    And according to IQVIA, fewer than 10% of launches are categorised as ‘excellent’. ... The same philosophy can be applied to product launches – if you’ve done it all perfectly once, why not reuse as much as you can the next time?

  • Beyoncé vs Paul Simon: achieving launch excellence Beyoncé vs Paul Simon: achieving launch excellence

    Despite this, they have two very different solo careers, requiring two very different launches. ... This must be someone you trust, who understands both pharma and product launches, and isn’t afraid of asking difficult questions.

  • Launch engagement Launch engagement

    are all core components of effective product launches. ... Tailoring each launch. Launching a new product is never easy – 40% of worldwide drug launches between 2009 and 2017 failed to meet their two-year sales forecast, according to a McKinsey

  • Successful product commercialisation: what can we learn from the rare disease setting? Successful product commercialisation: what can we learn from the rare disease setting?

    Rare diseases: setting the gold standard for successful product launches. A recent Deloitte Insights white paper found that three product characteristics are strongly associated with strong launch performance: priority review and ... The key to

  • How can virtual pharma companies de-risk new product launches? How can virtual pharma companies de-risk new product launches?

    5. Meeting market-specific compliance requirements. Finally, no product can reach the market without fully complying with the applicable regulatory requirements. ... Yet compliance doesn’t end at product launch. Pharma companies will still be subject

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

  • New hire and promotions announced at Evoke KYNE New hire and promotions announced at Evoke KYNE

    At Evoke KYNE, she has led a variety of communications initiatives across therapeutic areas, including patient advocacy relations, launches and product approvals.

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    In her new role, Heffron will be based in Zug, Switzerland, where she will aid the launch of bluebird’s first commercial product – its gene therapy  Zynteglo. ... Jason's extensive commercial experience, including the planning, preparation and

  • Novo Nordisk target Ablynx reshuffles its board Novo Nordisk target Ablynx reshuffles its board

    Hensen is the ideal person to lead the board moving forward and his wealth of experience is particularly relevant as we advance towards the potential approvals and global launches of our ... lead, wholly-owned product, caplacizumab, in addition to

  • Astellas promotes John Demaree Astellas promotes John Demaree

    In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.

  • The Medicines Company appoints Biogen's Tony Kingsley The Medicines Company appoints Biogen's Tony Kingsley

    Kingsley previously served as Biogen's executive vice president, global commercial operations, where the product launches he oversaw included the multiple sclerosis blockbuster Tecfidera (dimethyl fumerate).

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 52 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...